NAS
CLB icon

Nykredit A/S’s Core Laboratories CLB Stock Holding History

Nykredit A/S’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Buy
+1,380
New +$19.7K ﹤0.01% 1785

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Nykredit A/S's CLB Position: Q2 2026 in Review

Nykredit A/S opened a new position in Core Laboratories (CLB) in Q2 2026: 1,380 shares worth $16.1K. The stake represents ﹤0.01% of the portfolio and ranks #1785 among its holdings.

146 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Nykredit A/S held 1,380 shares of Core Laboratories worth $16.1K as of Q2 2026.
  • Core Laboratories was a new Nykredit A/S position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1785 holding.
  • 146 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.